BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 16029933)

  • 21. A silver coated dressing reduces the incidence of early burn wound cellulitis and associated costs of inpatient treatment: comparative patient care audits.
    Fong J; Wood F; Fowler B
    Burns; 2005 Aug; 31(5):562-7. PubMed ID: 15993301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonoperative management of pediatric burn injuries.
    Pizano LR; Corallo JP; Davies J
    J Craniofac Surg; 2008 Jul; 19(4):877-81. PubMed ID: 18650703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of treating infected skin grafts with Acticoat on immune cells.
    Mazurak VC; Burrell RE; Tredget EE; Clandinin MT; Field CJ
    Burns; 2007 Feb; 33(1):52-8. PubMed ID: 17079089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of toxic epidermal necrolysis in a pediatric patient with a nanocrystalline silver dressing.
    Asz J; Asz D; Moushey R; Seigel J; Mallory SB; Foglia RP
    J Pediatr Surg; 2006 Dec; 41(12):e9-12. PubMed ID: 17161178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A case report of the use of nanocrystalline silver dressing in the management of acute surgical site wound infected with MRSA to prevent cutaneous necrosis following revision surgery.
    Bhattacharyya M; Bradley H
    Int J Low Extrem Wounds; 2008 Mar; 7(1):45-8. PubMed ID: 18372271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The safety of nanocrystalline silver dressings on burns: a study of systemic silver absorption.
    Vlachou E; Chipp E; Shale E; Wilson YT; Papini R; Moiemen NS
    Burns; 2007 Dec; 33(8):979-85. PubMed ID: 17959313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of silver-coated dressing (Acticoat), chlorhexidine acetate 0.5% (Bactigrass), and silver sulfadiazine 1% (Silverdin) for topical antibacterial effect in Pseudomonas aeruginosa-contaminated, full-skin thickness burn wounds in rats.
    Ulkür E; Oncül O; Karagöz H; Celiköz B; Cavuşlu S
    J Burn Care Rehabil; 2005; 26(5):430-3. PubMed ID: 16151289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An overview of Acticoat dressing in wound management.
    Dowsett C
    Br J Nurs; 2003 Oct; 12(19 Suppl):S44-9. PubMed ID: 14593271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A clinical experience of treating exfoliative wounds using nanocrystalline silver-containing dressings (Acticoat).
    Yang JY; Huang CY; Chuang SS; Chen CC
    Burns; 2007 Sep; 33(6):793-7. PubMed ID: 17532147
    [No Abstract]   [Full Text] [Related]  

  • 30. Nanocrystalline silver (Acticoat) for itch relief in the burns patient.
    Brooks P; Phang KL; Moazzam A
    ANZ J Surg; 2007 Sep; 77(9):797. PubMed ID: 17685964
    [No Abstract]   [Full Text] [Related]  

  • 31. Efficacy of antimicrobial activity of slow release silver nanoparticles dressing in post-cardiac surgery mediastinitis.
    Totaro P; Rambaldini M
    Interact Cardiovasc Thorac Surg; 2009 Jan; 8(1):153-4. PubMed ID: 18948308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Silver absorption on burns after the application of Acticoat: data from pediatric patients and a porcine burn model.
    Wang XQ; Kempf M; Mott J; Chang HE; Francis R; Liu PY; Cuttle L; Olszowy H; Kravchuk O; Mill J; Kimble RM
    J Burn Care Res; 2009; 30(2):341-8. PubMed ID: 19165102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Healing at home: Comparing cohorts of children with medium-sized burns treated as outpatients with in-hospital applied Acticoat to those children treated as inpatients with silver sulfadiazine.
    Peters DA; Verchere C
    J Burn Care Res; 2006; 27(2):198-201. PubMed ID: 16566565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histopathological Changes of Organs (Lungs, Liver, Kidney, and Brain) After Using Two Types of AgiCoat and Acticoat Nanosilver Dressings on Deep Second-Degree Burn in Rat.
    Karimi H; Latifi NA; Mehrjerdi AZ; Jafarnejad B; Karimi AM
    J Burn Care Res; 2020 Jan; 41(1):141-150. PubMed ID: 31400763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incorrect Acticoat application causing iatrogenic injury to a child with a palmar burn.
    Sakata S; West S; McBride C; Taylor R
    Emerg Med Australas; 2008 Apr; 20(2):183-4. PubMed ID: 18377409
    [No Abstract]   [Full Text] [Related]  

  • 36. Acticoat and smith and nephew.
    Burd A
    Burns; 2012 Feb; 38(1):142; author reply 143. PubMed ID: 22103984
    [No Abstract]   [Full Text] [Related]  

  • 37. Benefit of hydrocolloid SSD dressing in the outpatient management of partial thickness burns.
    Muangman P; Muangman S; Opasanon S; Keorochana K; Chuntrasakul C
    J Med Assoc Thai; 2009 Oct; 92(10):1300-5. PubMed ID: 19845237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the penetration of nanocrystalline silver through various wound dressing mediums: An in vitro study.
    Potgieter MD; Meidany P
    Burns; 2018 May; 44(3):596-602. PubMed ID: 29290512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Scar outcome of children with partial thickness burns: A 3 and 6 month follow up.
    Gee Kee EL; Kimble RM; Cuttle L; Stockton KA
    Burns; 2016 Feb; 42(1):97-103. PubMed ID: 26546385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective, randomized trial of Acticoat versus silver sulfadiazine in the treatment of partial-thickness burns: which method is less painful?
    Varas RP; O'Keeffe T; Namias N; Pizano LR; Quintana OD; Herrero Tellachea M; Rashid Q; Ward CG
    J Burn Care Rehabil; 2005; 26(4):344-7. PubMed ID: 16006842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.